170 related articles for article (PubMed ID: 11162647)
21. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
23. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
Qin TN; Wang LL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.
Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
Cancer Lett; 2001 Jul; 168(2):173-81. PubMed ID: 11403922
[TBL] [Abstract][Full Text] [Related]
25. Cloning analysis of ferritin and the cisplatin-subunit for cancer cell apoptosis in Aplysia juliana hepatopancreas.
Zhu B; Huang L; Huang HQ
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Aug; 156(2):95-103. PubMed ID: 22579997
[TBL] [Abstract][Full Text] [Related]
26. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.
Francia G; Man S; Teicher B; Grasso L; Kerbel RS
Mol Cell Biol; 2004 Aug; 24(15):6837-49. PubMed ID: 15254249
[TBL] [Abstract][Full Text] [Related]
27. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling.
Koch M; Krieger ML; Stölting D; Brenner N; Beier M; Jaehde U; Wiese M; Royer HD; Bendas G
Biochem Pharmacol; 2013 Apr; 85(8):1077-90. PubMed ID: 23396090
[TBL] [Abstract][Full Text] [Related]
28. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
[TBL] [Abstract][Full Text] [Related]
29. Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
Fumoto S; Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Hiyama E; Noguchi T; Nishiyama M
Int J Oncol; 2008 Feb; 32(2):413-23. PubMed ID: 18202764
[TBL] [Abstract][Full Text] [Related]
30. Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line.
Duraj J; Pastorek M; Vitkovska J; Cholujova D; Gronesova P; Hunakova L; Sedlak J
Neoplasma; 2013; 60(6):627-34. PubMed ID: 23906297
[TBL] [Abstract][Full Text] [Related]
31. Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells.
Marverti G; Guaitoli G; Ligabue A; Frassineti C; Monti MG; Lombardi P; Costi MP
Amino Acids; 2012 Feb; 42(2-3):641-53. PubMed ID: 21814787
[TBL] [Abstract][Full Text] [Related]
32. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
Solár P; Sytkowski AJ
Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
[TBL] [Abstract][Full Text] [Related]
33. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice.
Peluso JJ; Gawkowska A; Liu X; Shioda T; Pru JK
Endocrinology; 2009 Nov; 150(11):4846-54. PubMed ID: 19797399
[TBL] [Abstract][Full Text] [Related]
34. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
Asakura T; Imai A; Ohkubo-Uraoka N; Kuroda M; Iidaka Y; Uchida K; Shibasaki T; Ohkawa K
Oncol Rep; 2005 Sep; 14(3):601-7. PubMed ID: 16077962
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
36. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase.
Passer BJ; Nancy-Portebois V; Amzallag N; Prieur S; Cans C; Roborel de Climens A; Fiucci G; Bouvard V; Tuynder M; Susini L; Morchoisne S; Crible V; Lespagnol A; Dausset J; Oren M; Amson R; Telerman A
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2284-9. PubMed ID: 12606722
[TBL] [Abstract][Full Text] [Related]
37. Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A.
Ma X; Duan H; Liu J; Mo Q; Sun C; Ma D; Wang J
Oncol Rep; 2015 Feb; 33(2):893-8. PubMed ID: 25420545
[TBL] [Abstract][Full Text] [Related]
38. Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 2000; 46(1):69-76. PubMed ID: 10601800
[TBL] [Abstract][Full Text] [Related]
39. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
40. [Comparative genomic hybridization for analysis of chromosomal changes in cisplatin-resistant ovarian cancer].
Kudoh K; Takano M; Koshikawa T; Yoshida S; Hirai M; Kikuchi Y; Nagata I; Miwa M; Uchida K
Hum Cell; 2000 Sep; 13(3):109-16. PubMed ID: 11197772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
